Valuation: STCube, Inc.

Market Cap 539B 359M 314M 289M 267M 507M 34.22B 516M 3.46B 1.36B 16.86B 1.35B 1.32B 57.95B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 481B 321M 280M 259M 239M 453M 30.57B 461M 3.09B 1.21B 15.06B 1.2B 1.18B 51.77B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24/10/24 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
26/08/24 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
28/03/24 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
06/09/23 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
21/03/23 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
08/03/22 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
28/12/20 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
18/12/20 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
12/07/20 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
02/03/20 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
25/05/18 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
25/04/18 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
19/09/16 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day+6.30%
1 week-2.10%
Current month-8.22%
1 month-25.61%
3 months-48.84%
6 months-12.28%
Current year-3.29%
1 week 7,260
Extreme 7260
8,800
1 month 7,260
Extreme 7260
11,750
Current year 6,950
Extreme 6950
22,500
1 year 6,810
Extreme 6810
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 29/03/2013
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 01/03/2014
Director TitleAgeSince
Director/Board Member 61 01/03/2013
Director/Board Member 54 01/03/2013
Director/Board Member 62 01/03/2014
Date Insider Type Main position Quantity % Market Cap.
03/12/24
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
03/12/24Buy

Chief Financial Officer

47,582 0.0730%
03/12/24Buy

Chief Technology Officer

164,014 0.2515%
Change 5-day change 1-year change 3-year change Capi.($)
+6.30%-2.10%+0.51%-44.62% 359M
+1.81%-4.15%+38.73%+17.71% 116B
-5.09%-7.08%+337.45%+908.71% 53.52B
-2.96%-0.77%+161.51%+386.56% 49.75B
+0.21%-8.38%+109.72%+218.46% 39.83B
-0.16%-5.01%+128.57%+98.80% 30.12B
+0.49%-2.68%+20.30%+53.25% 29.4B
+1.27%-1.64%-18.60%-34.78% 22.67B
0.00%-9.32%+12.42%+68.21% 18.45B
-2.82%-15.87%+71.30%+130.40% 17.07B
Average -0.10%-4.37%+86.19%+180.27% 37.67B
Weighted average by Cap. -0.56%-4.17%+107.33%+227.84%

Financials

2024 2025
Net sales 11.3B 7.52M 6.58M 6.07M 5.61M 10.64M 718M 10.82M 72.53M 28.48M 354M 28.25M 27.63M 1.22B 6.98B 4.65M 4.07M 3.75M 3.47M 6.58M 444M 6.69M 44.84M 17.61M 219M 17.46M 17.08M 751M
Net income -21.44B -14.28M -12.49M -11.52M -10.64M -20.19M -1.36B -20.52M -138M -54.04M -671M -53.6M -52.44M -2.31B -21.8B -14.52M -12.7M -11.71M -10.82M -20.53M -1.38B -20.87M -140M -54.96M -682M -54.51M -53.32M -2.34B
Net Debt -79.55B -52.98M -46.34M -42.74M -39.48M -74.91M -5.05B -76.17M -511M -201M -2.49B -199M -195M -8.56B -57.42B -38.24M -33.45M -30.85M -28.49M -54.07M -3.65B -54.98M -369M -145M -1.8B -144M -140M -6.18B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
10/07/26 ₩7,930.00 +6.30% 251,746
09/07/26 ₩7,460.00 +0.54% 190,283
08/07/26 ₩7,420.00 -6.31% 244,834
07/07/26 ₩7,920.00 -2.10% 201,443
06/07/26 ₩8,090.00 -0.12% 206,421
  1. Stock Market
  2. Stocks
  3. A052020 Stock